The data presented suggest that a potentially interesting therapeutic strategy to improve the outcome of necrotising pneumonia, and notably to control leukopenia, could be to target and inhibit leucocidin receptors, in particular C5aR. The gene discussed is C5AR1; the disease is Decreased total leukocyte count.